Does Cigna Cover Ozempic? Coverage & Cost Guide 2026

Does Cigna Cover Ozempic for Type 2 Diabetes?

Cigna generally covers Ozempic when a doctor prescribes it for type 2 diabetes. Coverage requires prior authorization and a documented diagnosis on your medical record.

Cigna's own national coverage policy for GLP-1 diabetes drugs, last reviewed in June 2026, approves Ozempic for members age 18 and older who carry a type 2 diabetes diagnosis. Approval runs for one year at a time before it needs renewal.

That policy covers both the Ozempic injection pen and Ozempic tablets. The tablet line grew in 2026: the FDA approved a name change that January, turning the higher-strength Rybelsus tablets (1.5 mg, 4 mg, and 9 mg) into Ozempic tablets. Cigna's coverage policy absorbed that rename the same year.

Ozempic actually carries three separate FDA approvals a prescriber can cite on a Cigna prior authorization request. These are glycemic control in type 2 diabetes, cardiovascular risk reduction in adults who have type 2 diabetes and established heart disease, and slowing kidney decline in adults who have type 2 diabetes and chronic kidney disease. Any of the three can support the request when the diagnosis fits.

Cigna's national policy does not spell out a universal step-therapy rule, such as a required metformin trial, for the diabetes indication. Cigna administers thousands of different employer-sponsored plan designs, and some employers add their own step-therapy or lab-documentation rules on top of Cigna's baseline criteria. Your plan's own Summary of Benefits, not a general rule, is what actually applies to you.

Does Cigna Cover Ozempic for Weight Loss?

No, not as a rule. Cigna's own coverage policy for Ozempic states plainly that the drug is "not FDA-approved for weight loss" and lists weight loss as a use the policy does not cover.

That is because Ozempic's own FDA label does not include a weight-management indication. The semaglutide product built specifically for that use is Wegovy, a related but separate drug with its own approval and its own Cigna coverage rules.

Cigna does run a dedicated weight-loss drug program through Evernorth. It is called EncircleRx, and it launched January 1, 2025. Employers choose whether to buy into it, and if they do, coverage is built around a BMI threshold set by the specific plan design the employer selected.

EncircleRx pairs GLP-1 coverage with required participation in Omada Health's digital lifestyle coaching program. Evernorth also negotiated a spend-growth cap with Novo Nordisk and Eli Lilly, so participating employers do not see year-over-year cost increases above a set percentage.

EncircleRx's drug list covers Wegovy, Zepbound, Saxenda, and Foundayo. Ozempic is not one of the drugs it covers, because the program is built around drugs with an FDA weight-management approval, and Ozempic does not carry one. Employers who never purchased any obesity-medication benefit can exclude weight-loss GLP-1 coverage entirely, no matter which drug is requested.

Evernorth and the Cigna Prior Authorization Process

Evernorth is Cigna's pharmacy benefit manager. It sets the formulary, writes the prior authorization criteria, and processes the actual review when your prescriber submits a request for Ozempic.

For the type 2 diabetes indication, the process generally involves a few steps. Your prescriber submits the diabetes diagnosis, confirms your age, and, for some plan designs, documents recent lab work such as an A1C result.

Some Cigna plans use an automated approval path. If your pharmacy claims history already shows a recent fill of another oral diabetes medication, the system can approve Ozempic without a full manual review. If that history is not there, standard manual review applies instead.

Standard prior authorization reviews commonly take up to two weeks. Expedited review is available for urgent clinical situations, and it typically moves faster. Once approved, that authorization is generally good for one year before it needs to be renewed with updated documentation.

Formulary Tiers and Your Ozempic Copay

An approved prior authorization does not guarantee a low copay. Where Ozempic sits on your specific plan's formulary tier list matters just as much as whether the drug is approved at all.

Most Cigna formularies group drugs into tiers, with lower tiers carrying a lower copay and higher tiers carrying a higher one, sometimes a percentage of the drug's cost rather than a flat dollar amount. Ozempic commonly sits on a mid-to-higher tier because it is a brand-name specialty-adjacent drug rather than a low-cost generic.

Two Cigna members with the same approved prior authorization can end up paying very different amounts. It depends on which specific plan their employer selected, whether that plan uses a flat copay or coinsurance structure, and whether the member has met their deductible for the year.

The only way to know your actual tier and copay is to check your plan's formulary document or call the number on your Cigna ID card. A tier can also change from one plan year to the next, so it is worth rechecking at open enrollment.

Cigna Medicare and Ozempic: What Changed in 2025

If you are asking whether "Cigna Medicare" covers Ozempic, the starting fact has changed. The Cigna Group completed the sale of its Medicare Advantage, Medicare Part D, and CareAllies businesses to Health Care Service Corporation on March 19, 2025, in a deal valued near $3.3 billion.

That means Cigna-branded Medicare Advantage and Part D plans no longer exist for 2026. Former Cigna Medicare members were transitioned to HCSC's plans as part of that sale. Evernorth still supplies pharmacy benefit services to that book of business under a four-year agreement with HCSC, but the plan sponsor is HCSC now, not Cigna.

If your Medicare coverage came through Cigna before 2025, your current Ozempic coverage question belongs to HCSC or whichever carrier you are enrolled with today, not Cigna directly. For general Medicare Part D rules on GLP-1 coverage, including the temporary Medicare GLP-1 Bridge program and the statutory weight-loss-drug exclusion, see our Ozempic insurance coverage guide or check CMS directly at medicare.gov.

Cigna still operates commercial employer plans and Medicaid managed-care plans in select states. Those are unaffected by the Medicare sale, and the diabetes-versus-weight-loss coverage split described above still applies to them.

How Much Does Ozempic Cost on a Cigna Plan?

Ozempic's list price runs about $997 to $1,000 per month without any coverage. With Cigna coverage for the diabetes indication and a favorable formulary tier, many members pay a flat copay well below that figure, though the exact amount depends on your tier and deductible status.

On top of Cigna coverage, Novo Nordisk's savings card can bring the cost as low as $25 per month for commercially insured members, for up to 48 months. Members with Medicare, Medicaid, TRICARE, or VA coverage are excluded from that card by federal law.

If your Cigna plan does not cover Ozempic at all, or if you are uninsured, Novo Nordisk's NovoCare Patient Assistance Program provides free Ozempic to income-eligible uninsured patients with a documented type 2 diabetes diagnosis. NovoCare's self-pay pharmacy also sells Ozempic directly, with pricing around $199 to $499 per month depending on dose.

For the full breakdown of these programs, including eligibility rules and current pricing, see our Ozempic insurance coverage guide. A sibling guide on a different insurer and drug combination, does Humana cover Zepbound, walks through a similar Medicare and prior-authorization picture for a different plan.

How to Check Your Coverage and Appeal a Denial

The fastest way to check your own Ozempic coverage is to call the member services number on your Cigna ID card and ask three things: is Ozempic on your plan's formulary, what tier is it on, and does prior authorization apply to your specific plan.

You can also log into your Cigna member portal and search the drug formulary tool directly, or ask your prescriber's office to run a benefits check before submitting the prior authorization request. This avoids a denial caused by a formulary mismatch rather than a genuine coverage gap.

If Cigna denies your Ozempic request, the case is not closed. Start by asking for the specific denial reason in writing. A denial for "weight loss only" needs a different response than a denial for missing lab documentation.

An effective appeal has your prescriber submit a clinical letter that addresses the stated denial reason directly. Include updated labs, such as a recent A1C, and note any contraindication to a step-therapy drug the plan required first. Cigna's appeals process typically allows both an internal appeal and, if that fails, an external review by an independent party.

While an appeal is pending, ask your prescriber about interim options. These include the Novo Nordisk savings card if you have commercial coverage, NovoCare self-pay pricing, or, if your diagnosis actually supports it, whether Wegovy through EncircleRx is a better-documented path than Ozempic.

What to Look For in a Body-Composition Scale

A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.

GE Smart Scale for Body Weight: 8-Electrode Digital Bathroom Scale for Weight Fat BMI Muscle Mass Full Body Composition Analyzer 50 Measurements Bluetooth Highly Accurate Weighing Machine 400lb Black

GE

View on Amazon →

Etekcity Smart Scale for Body Weight, FSA&HSA Eligible, Bathroom Digital Weighing Scale with BMI, Body Fat, Muscle Mass, Accurate Bluetooth Home User Health Equipment Sync Apps, LED, Tempered glass

Etekcity

View on Amazon →